KIMS Q3 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹998 Cr
verified against source
Revenue YoY
29.2%
reported change
EBITDA
₹193 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
KIMS reported record Q3 FY26 revenue of ₹998 crore (up 29.2% YoY), driven by strong volume growth across IP (61,139, +13.2% YoY) and OP (5.85 lakh, +24.5% YoY) segments, alongside robust ARPOB expansion of 20.5% YoY. However, EBITDA declined 2.2% YoY to ₹193 crore with margins compressing 550bps to 20.4% due to drag from seven newly commissioned hospitals over the past 9-12 months. PAT fell sharply to ₹52 crore (down 39.9% YoY) reflecting elevated operating costs at ramping units. Management guided Thane and Mahadevapura to break-even by Q1 FY27 and Electronic City by Q3 FY27, with FY27 capex guidance of ₹500-600 crore. Chennai expansion via 26-year Andhra Pradesh Sabha agreement signals South India consolidation strategy. Key risk: margin pressure from new unit ramp-ups and delayed insurance empanelments in Maharashtra cluster (Nashik, Thane) where top-5 insurer empanelment completion is targeted for Q4 FY26.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects both Thane and Mahadevapura hospitals to break-even on a quarterly basis by end of Q1 FY27, approximately 15-18 months post-commissioning.
- Electronic City hospital (commissioned December 2025) is expected to break-even on a quarterly basis by Q3 FY27, with revenue ramp-up being the key driver as doctor onboarding is complete.
- Full closure on capex for ongoing expansion will require another ₹500-600 crore in FY27. FY28 will see only maintenance capex with no new hospital commissioning planned.
- KIMS has entered a 26-year agreement with Andhra Pradesh Sabha to construct and operate a hospital in Chennai, with construction expected to complete within 2 years.
Risks flagged
- Seven hospitals commissioned in 2025 are creating EBITDA erosion as they ramp up. Management acknowledges this drag on margins, with EBITDA declining 2.2% YoY and margins compressing to 20.4% versus 25.9% in Q3 FY25.
- Nashik and Thane units face 30% revenue exposure to insurance which is delayed. Only 2 of top-5 insurers empaneled so far; remaining 3 targeted for completion by Q4 FY26. Analyst questioned why negotiations took longer than anticipated.
- Andhra cluster experienced 45-60 day disruption due to state government strike on ROG payments, causing significant volume dip. Payer mix contribution from state government declining as expansion moves to other states.
- Telangana cluster running at 52.5% occupancy but 200-250 beds under renovation (85% on available beds). Management guided only high single-digit growth for mature Telangana cluster, with double-digit contingent on new facility additions.
Key quotes
- This is a record-breaking quarter with highest ever revenue crossing the 1,000 crore. Though Q3 is traditionally a weak quarter, we have raced past with growing results despite the usual initial pressures associated with the new units.
- Between Thane and Mahadevapura, towards the end of Q1 next financial year we should become EBITDA positive or EBITDA neutral. Electronic City might take a little longer by May because we commissioned it only in the month of December.
- In a tier 2 market you have a mix of cash, insurance and corporate. Insurance and corporate because they take time and it's a very price-sensitive market. That is why the delayed ramp up. But otherwise fundamentally we don't see any issue in Thane or Bangalore.
Research modules